Reliable partner in rheumatology

Autoimmune diseases are very common all over the world and come in many different forms. However different these conditions may be, they all imply a range of chronic treatment needs across a broad spectrum of patients. Methotrexate is a crucial drug in the treatment of autoimmune diseases. It is used for a variety of autoimmune diseases, including rheumatic diseases, and has been a pillar at medac for many years.
Reliable partner in rheumatology

Improving therapies again and again

At medac, we strongly value patients' autonomy and quality of life. We have consistently addressed unmet medical needs by continuously improving and refining the medications in our product portfolio. Today, medac is recognised as a leading supplier of subcutaneous methotrexate and is highly regarded for its reliable services and supplies.

Dedicated to research and scientific exchange

medac itself is involved in autoimmune disease research as well as in the development of drugs and diagnostics in this area and promotes public research. Our aim is to continuously generate new findings that have a positive impact on everyday clinical practice and the daily lives of patients. Beyond this, medac also encourages scientific exchange by organising global symposia on autoimmune diseases, to provide further training for specialists and to raise awareness. In doing so, we are working closely together with our broad network of authorities, key opinion leaders, academia and other relevant players.

Our Focus Areas


Quality and innovation in supporting cancer care

Oncology has been a key focus and cornerstone of medac's success story throughout our corporate history. We have a strong, decades-long track record of reliable supply of medicinal products and supportive therapeutics across a range of oncological indications.


Addressing unmet needs with urological therapies

Urology is a focus area of highest importance for medac. We have been active in this field from almost the very beginning of our company and are focused on developing a range of proprietary products that address a variety of unmet therapeutic needs.


Innovative and life-saving treatment options

Haematology is a focus area of high importance for medac. To find new treatment approaches for rare diseases, medac addresses critical needs in haematology and has developed innovative products to improve the outcomes of stem cell transplantation.

Reporting an adverse event

Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to medac Pharma at info@medacpharma.co.uk

We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).



Please enter your email address and password to log in.